Exor N.V. 13F Filing — Q4 2023 Positions | AlphaSMO

Exor N.V. — Q4 2023 13F Holdings

Name: Exor N.V. — 13F Holdings, Q4 2023
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001589122

Total reported value

$5.4B

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	✓	Ikena Oncology INC	Stock-Other	84.23%	+4.27%	—
2	CLVT	Clarivate Plc	Stock-Other	15.77%	-0.87%	+102.42%